Stockscreener 앱 받기
1.18
2.48%
-0.03
Inovio Pharmaceuticals Inc 주식(INO)의 최신 뉴스
Inovio Pharmaceuticals Inc. stock underperforms Thursday when compared to competitors - MarketWatch
Inovio Pharmaceuticals, Inc. (INO) Stock Price, News, Quote & History - Yahoo! Finance Canada
Inovio Pharmaceuticals, Inc. (INO) stock price, news, quote and history - Yahoo Finance UK
Inovio Pharmaceuticals stock trades lower as FDA date nears - AD HOC NEWS
Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day - MarketWatch
INO Looks 490.5% Overvalued on GF Value™ - GuruFocus
Inovio Pharmaceuticals stock gains as price crosses 200-day moving average - AD HOC NEWS
Inovio Pharmaceuticals stock trades near 52-week midpoint as analysts keep Moderate Buy view - AD HOC NEWS
Inovio at H.C. Wainwright conference: FDA review and launch loom By Investing.com - Investing.com South Africa
Inovio Nears FDA Decision on INO-3107 as Oct. 30 PDUFA Date Looms - es.tradingview.com
Inovio at H.C. Wainwright conference: FDA review and launch loom - Investing.com India
Inovio Pharmaceuticals Nears Oct. 30 FDA Decision for INO-3107 in RRP - TradingView
INOVIO at Cantor Fitzgerald healthcare conference: FDA decision nears By Investing.com - Investing.com India
Inovio Pharmaceuticals Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
INOVIO Steps Up Investor Outreach at New York Conferences - MyChesCo
INO Stockholders Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Class Action Lawsuit – Contact Bronstein, Gewirtz and Grossman, LLC Today! - ACCESS Newswire
INOVIO to Participate in Upcoming Investor Conferences - Eastern Progress
Inovio Pharmaceuticals Stock Price Forecast. Should You Buy INO? - StockInvest.us
Inovio Pharmaceuticals stock gains as analysts see sharp upside - ad-hoc-news.de
Investor talks begin Sept. 9 as INOVIO joins two conferences - Stock Titan
Inovio Pharmaceuticals Inc. stock underperforms Monday when compared to competitors - MarketWatch
Inovio stock holds in low single digits as losses weigh on outlook - ad-hoc-news.de
Inovio Pharmaceuticals Inc (NASDAQ: INO) Share Price, INO Stock News, INO Share Price & Updates - kalkine.ca
Inovio Pharmaceuticals Inc. (INO) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research
Inovio: The Final Countdown To A Binary FDA Decision - Seeking Alpha
Inovio Pharmaceuticals Inc. Stock Rises 5.9%, Outperforms Peers - Bitget
Inovio Pharmaceuticals Inc. stock underperforms Friday when compared to competitors - MarketWatch
Inovio (INO) Results Versus Estimates: Profit Per Share Clears Its Benchmark in Latest Trading; Market Response: The Stock Ends Down 6.92%Pre-Earnings Setup - Vinanet
Inovio Pharmaceuticals Company Profile & Introduction - Moomoo
INO, MRNA, NVAX, EBS Jump Overnight: Trump Promises Full Hantavirus Report As Deadly Outbreak Sparks Vaccine Rally - Stocktwits
Inovio Pharmaceuticals Inc. Stock Rallies 8.3%, Outperforms Peers - Bitget
Inovio (INO) Earnings Check: The Available Earnings Metric Delivers a Beat at the Close; Post-Report Move: The Stock Ends Up 4.35% in the Latest ReadingFinancial Data - Vinanet
Inovio Pharmaceuticals Inc. Stock Rallies 5.5%, Outperforms Peers - Bitget
Q3 EPS Estimate for Inovio Pharmaceuticals Raised by Analyst - MarketBeat
INO Jumps As Inovio Wins Upgrade Ahead Of FDA Decision - timothysykes.com
Inovio Stock Jumps As Jefferies Upgrade Bets On FDA Decision - StocksToTrade
Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to "Hold" at Wall Street Zen - MarketBeat
INOVIO Sets Aug. 12 Earnings Update With Business Review - MyChesCo
Inovio Pharmaceuticals Highlights FDA Inspection Completion and INO-3107 Regulatory Progress in Q2 2026 Earnings CallDividend Earnings Report - Vinanet
HC Wainwright Issues Negative Estimate for INO Earnings - MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO) Upgraded to Strong-Buy at Zacks Research - MarketBeat
Analysts Have Conflicting Sentiments on These Healthcare Companies: Kura Oncology (KURA) and Inovio Pharmaceuticals (INO) - The Globe and Mail
INO Upgraded by Jefferies -- Price Target Raised to $3.00 - GuruFocus
Piper Sandler Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Maintains Target Price $4 - Moomoo
Jefferies Maintains Inovio Pharmaceuticals(INO.US) With Buy Rating, Raises Target Price to $3 - Moomoo
H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target - Investing.com
H.C. Wainwright reiterates Neutral on Inovio stock, $2.50 target By Investing.com - Investing.com Canada
Jefferies upgrades Inovio stock rating on FDA review progress - Investing.com
Inovio Q2 2026 slides: INO-3107 on track for Oct FDA decision - Investing.com Nigeria
Jefferies upgrades Inovio stock rating on FDA review progress By Investing.com - Investing.com Canada
Inovio Pharmaceuticals, Inc. (NASDAQ:INO) Receives Consensus Recommendation of "Hold" from Analysts - MarketBeat
Inovio Pharmaceuticals (NASDAQ:INO): What Does the Latest Update Mean for Regulatory Progress? - Kalkine Media
4.04%
1.11%
자본화:
|
볼륨(24시간):